Pål Andre Holme

Adjunct Professor - Department of Haematology
Image of Pål Andre Holme
Norwegian version of this page
Username
Visiting address Sognsvannsveien 20 OUS Rikshospitalet 0372 Oslo
Postal address Postboks 4950 Nydalen OUS, Rikshospitalet 0424 Oslo

Publications

  • Johansen, Silje; Lægreid, Ingvild Jenssen; Ernstsen, Siw Leiknes; Azrakhsh, Nessar Ahmad; Kittang, Astrid Marta Olsnes & Lindås, Roald [Show all 13 contributors for this article] (2021). Thrombosis and thrombocytopenia after HPV vaccination. Journal of Thrombosis and Haemostasis. ISSN 1538-7933. doi: 10.1111/jth.15604.
  • Jiménez-Yuste, Victor; Rodríguez-Merchán, E. Carlos; Matsushita, Tadashi & Holme, Pål Andre (2021). Concomitant use of bypassing agents with emicizumab for people with haemophilia A and inhibitors undergoing surgery. Haemophilia. ISSN 1351-8216. 27(4), p. 519–530. doi: 10.1111/hae.14322.
  • Astermark, Jan; Ay, Cihan; Carvalho, Manuela; D'Oiron, Roseline; Moerloose, Philippe De & Dolan, Gerard [Show all 18 contributors for this article] (2021). New Inhibitors in the Ageing Population: A Retrospective, Observational, Cohort Study of New Inhibitors in Older People with Hemophilia. Thrombosis and Haemostasis. ISSN 0340-6245. doi: 10.1055/a-1642-4067.
  • Holm, Sverre; Kared, Hassen; Michelsen, Annika Elisabet; Kong, Xiang Yi; Dahl, Tuva Børresdatter & Schultz, Nina Haagenrud [Show all 21 contributors for this article] (2021). Immune complexes, innate immunity, and NETosis in ChAdOx1 vaccine-induced thrombocytopenia. European Heart Journal. ISSN 0195-668X. 42(39), p. 4064–4072. doi: 10.1093/eurheartj/ehab506. Full text in Research Archive
  • Reding, Mark T.; Pabinger, Ingrid; Holme, Pål Andre; Poulsen, Lone; Negrier, Claude & Chalasani, Pavani [Show all 11 contributors for this article] (2021). Confirmed long-term safety and efficacy of prophylactic treatment with BAY 94–9027 in severe haemophilia A: final results of the PROTECT VIII extension study. Haemophilia. ISSN 1351-8216. 27(3), p. e347–e356. doi: 10.1111/hae.14297.
  • Schultz, Nina Haagenrud; Glosli, Heidi; Bjørnsen, Stine & Holme, Pål Andre (2021). The effect of emicizumab and bypassing agents in patients with hemophilia – An in vitro study. Research and Practice in Thrombosis and Haemostasis. ISSN 2475-0379. 5(5), p. 1–7. doi: 10.1002/rth2.12561. Full text in Research Archive
  • Måseide, Ragnhild Johanne; Berntorp, Erik; Nummi, Vuokko; Lassila, Riitta; Tjønnfjord, Geir E. & Holme, Pål A. (2021). Bleeding phenotype of patients with moderate haemophilia A and B assessed by thromboelastometry and thrombin generation. Haemophilia. ISSN 1351-8216. p. 1–10. doi: 10.1111/hae.14355.
  • Schultz, Nina Haagenrud; Sørvoll, Ingvild Hausberg; Michelsen, Annika; Munthe, Ludvig Andre; Lund-Johansen, Fridtjof & Ahlen, Maria Therese [Show all 11 contributors for this article] (2021). Thrombosis and thrombocytopenia after CHADOX1 NCoV-19 vaccination. New England Journal of Medicine. ISSN 0028-4793. 384(22), p. 2124–2130. doi: 10.1056/NEJMoa2104882.
  • Schultz, Nina Haagenrud; Fareed, Jawed & Holme, Pål Andre (2021). Investigation of the Optimal Dose aPCC in Reversing the Effect of Factor Xa Inhibitors—An In Vitro Study. Clinical and applied thrombosis/hemostasis. ISSN 1076-0296. 27, p. 1–7. doi: 10.1177/10760296211021156.
  • Måseide, Ragnhild Johanne; Berntorp, Erik; Astermark, Jan; Hansen, Jessica; Olsson, Anna & Bruzelius, Maria [Show all 11 contributors for this article] (2021). Haemophilia early arthropathy detection with ultrasound and haemophilia joint health score in the moderate haemophilia (MoHem) study. Haemophilia. ISSN 1351-8216. 27(2), p. e253–e259. doi: 10.1111/hae.14245. Full text in Research Archive
  • Qvigstad, Christian; Tait, R. Campbell; de Moerloose, Philippe & Holme, Pål Andre (2020). Hematuria in aging men with hemophilia: Association with factor prophylaxis. Research and Practice in Thrombosis and Haemostasis. ISSN 2475-0379. 4(2), p. 309–317. doi: 10.1002/rth2.12298. Full text in Research Archive
  • Kempton, Christine L.; Makris, Michael & Holme, Pål Andre (2020). Management of comorbidities in haemophilia. Haemophilia. ISSN 1351-8216. doi: 10.1111/hae.14013.
  • Qvigstad, Christian; Sørensen, Lars A Q; Tait, R. Campbell; De Moerloose, Philippe & Holme, Pål Andre (2020). Macroscopic hematuria as a risk factor for hypertension in ageing people with hemophilia and a family history of hypertension. Medicine. ISSN 0025-7974. 99(9), p. 1–8. doi: 10.1097/MD.0000000000019339. Full text in Research Archive
  • Måseide, Ragnhild Johanne; Berntorp, Erik; Astermark, Jan; Olsson, Anna; Bruzelius, Maria & Frisk, Tony [Show all 10 contributors for this article] (2020). Joint health and treatment modalities in Nordic patients with moderate haemophilia A and B – The MoHem study. Haemophilia. ISSN 1351-8216. 26(5), p. 891–897. doi: 10.1111/hae.14114. Full text in Research Archive
  • Gorkom, Britta; Holme, Pål Andre; Joch, Christine; Rogosch, Tobias; Feussner, Annette & McKeand, William [Show all 8 contributors for this article] (2020). Pharmacokinetics and pharmacodynamics of a recombinant fusion protein linking activated coagulation factor VII with human albumin (rVIIa-FP) in patients with congenital FVII deficiency. Hematology. ISSN 1024-5332. 25(1), p. 17–25. doi: 10.1080/16078454.2019.1700329. Full text in Research Archive
  • Tjønnfjord, Eirik; Holme, Pål Andre; Darne, Bernadette; Khelif, Abderrahim; Waage, Anders & Michel, Marc [Show all 8 contributors for this article] (2020). Long-term outcomes of patients treated with rituximab as second-line treatment for adult immune thrombocytopenia – Follow-up of the RITP study. British Journal of Haematology. ISSN 0007-1048. 191(3), p. 460–465. doi: 10.1111/bjh.16672. Full text in Research Archive
  • Chowdary, Pratima; Carcao, Manuel; Holme, Pål Andre; Jiménez-Yuste, Victor; Lentz, Steven R. & Møss, Judi [Show all 11 contributors for this article] (2019). Fixed doses of N8-GP prophylaxis maintain moderate-to-mild factor VIII levels in the majority of patients with severe hemophilia A. Research and Practice in Thrombosis and Haemostasis. ISSN 2475-0379. 3(3), p. 542–554. doi: 10.1002/rth2.12220. Full text in Research Archive
  • Lalezari, Shadan; Reding, Mark T.; Pabinger, Ingrid; Holme, Pål Andre; Negrier, Claude & Chalasani, Pavani [Show all 10 contributors for this article] (2019). BAY 94-9027 prophylaxis is efficacious and well tolerated for up to >5 years with extended dosing intervals: PROTECT VIII extension interim results. Haemophilia. ISSN 1351-8216. 25(6), p. 1011–1019. doi: 10.1111/hae.13853. Full text in Research Archive
  • Curry, Nicola; Albayrak, Canan; Escobar, Miguel; Holme, Pål Andre; Kearney, Susan & Klamroth, Robert [Show all 14 contributors for this article] (2019). Once-weekly prophylaxis with glycoPEGylated recombinant factor VIII (N8-GP) in severe haemophilia A: Safety and efficacy results from pathfinder 2 (randomized phase III trial). Haemophilia. ISSN 1351-8216. 25(3), p. 373–381. doi: 10.1111/hae.13712. Full text in Research Archive
  • Andersen, May-Linn Fauske; Holme, Pål Andre & Tjønnfjord, Geir Erland (2019). Surgical intervention in patients with severe bleeding disorder 1997-2014. Tidsskrift for Den norske legeforening. ISSN 0029-2001. 139(8), p. 709–712. doi: 10.4045/tidsskr.18.0592.
  • Ljungkvist, Marcus; Strandberg, Karin; Berntorp, Erik; Chaireti, Roza; Holme, Pål Andre & Larsen, Ole Halfdan [Show all 10 contributors for this article] (2019). Evaluation of a standardized protocol for thrombin generation using the calibrated automated thrombogram: A Nordic study. Haemophilia. ISSN 1351-8216. p. 1–9. doi: 10.1111/hae.13640. Full text in Research Archive
  • Schultz, Nina Haagenrud; Holme, Pål Andre; Bjørnsen, Stine; Henriksson, Carola; Sandset, Per Morten & Jacobsen, Eva-Marie (2018). The impact of rivaroxaban on primary hemostasis in patients with venous thrombosis. Platelets. ISSN 0953-7104. doi: 10.1080/09537104.2018.1557618.
  • Yaddehi Gamage, Thilini Hansamali Gamage; Gunnes, Gjermund; Lee, Robert Hugh; Louch, William Edward; Holmgren, Asbjørn & Bruton, Joseph D. [Show all 19 contributors for this article] (2018). STIM1 R304W causes muscle degeneration and impaired platelet activation in mice. Cell Calcium. ISSN 0143-4160. 76, p. 87–100. doi: 10.1016/j.ceca.2018.10.001. Full text in Research Archive
  • Holme, Pål Andre & Tjønnfjord, Geir Erland (2018). Continuous infusion of simoctocog alfa in haemophilia A patients undergoing surgeries. Haemophilia. ISSN 1351-8216. p. 1–6. doi: 10.1111/hae.13625. Full text in Research Archive
  • Qvigstad, Christian; Tait, Robert Cambell; Rauchensteiner, Stephan; Berntorp, Erik; de Moerloose, Philippe & Schutgens, Roger E. [Show all 7 contributors for this article] (2018). The elevated prevalence of risk factors for chronic liver disease among ageing people with hemophilia and implications for treatment. Medicine. ISSN 0025-7974. 97:e12551(39), p. 1–7. doi: 10.1097/MD.0000000000012551. Full text in Research Archive
  • Schultz, Nina Haagenrud; Lundblad, Runar & Holme, Pål Andre (2018). Activated prothrombin complex concentrate to reverse the factor Xa inhibitor (apixaban) effect before emergency surgery: A case series. Journal of Medical Case Reports. ISSN 1752-1947. 12(138). doi: 10.1186/s13256-018-1660-9.
  • Holme, Pål Andre; Tjønnfjord, Geir Erland & Batorova, A (2017). Continuous infusion of coagulation factor concentrates during intensive treatment. Haemophilia. ISSN 1351-8216. 24(1), p. 24–32. doi: 10.1111/hae.13331.
  • Osooli, Mehdi; Carlsson, Katarina Steen; Baghaei, Fariba; Holmström, Margareta; Rauchensteiner, Stephan & Holme, Pål Andre [Show all 9 contributors for this article] (2017). The association between health utility and joint status among people with severe haemophilia A: findings from the KAPPA register. Haemophilia. ISSN 1351-8216. 23(3), p. e180–e187. doi: 10.1111/hae.13231.
  • Berntorp, Erik; Dargaud, Yesim; Hart, Daniel; Lobet, Sébastien; Mancuso, Maria Elisa & d'Oiron, Roseline [Show all 26 contributors for this article] (2017). The second Team Haemophilia Education Meeting, 2016, Frankfurt, Germany. European Journal of Haematology. ISSN 0902-4441. 98, p. 1–15. doi: 10.1111/ejh.12828.
  • Schultz, Nina Haagenrud; Tran, Hoa Thi Tuyet; Bjørnsen, Stine; Henriksson, Carola; Sandset, Per Morten & Holme, Pål Andre (2017). The reversal effect of prothrombin complex concentrate (PCC), activated PCC and recombinant activated factor VII against anticoagulation of Xa inhibitor. Thrombosis Journal. ISSN 1477-9560. 15(1). doi: 10.1186/s12959-017-0129-1.
  • Holme, Pål Andre; Combescure, Christophe; Tait, Robert Cambell; Berntorp, Erik E.; Rauchensteiner, Stephan & de Moerloose, Philippe R. (2016). Hypertension, haematuria and renal functioning in haemophilia - a cross-sectional study in Europe. Haemophilia. ISSN 1351-8216. 22(2), p. 248–255. doi: 10.1111/hae.12847.
  • Berger, Karin B.; Schopohl, Dorothee; Lowe, Gordon; Holme, Pål Andre; Tait, Robert Cambell & Combescure, Christophe [Show all 8 contributors for this article] (2016). How to compare cardiovascular disease and risk factors in elderly patients with haemophilia with the general population. Haemophilia. ISSN 1351-8216. 22(5), p. e406–e416. doi: 10.1111/hae.13069.
  • Barratt-Due, Andreas; Fløisand, Yngvar; Lang, Hilde Elisabeth; Kvam, Ann Kristin; Holme, Pål Andre & Bergseth, Grete [Show all 8 contributors for this article] (2016). Complement activation is a crucial pathogenic factor in catastrophic antiphospholipid syndrome. Rheumatology. ISSN 1462-0324. doi: 10.1093/rheumatology/kew040. Full text in Research Archive
  • James, PD; Mahlangu, J; Bidlingmaier, C; Mingot-Castellano, María Eva; Chitlur, M & Fogarty, PF [Show all 13 contributors for this article] (2016). Evaluation of the utility of the ISTH-BAT in haemophilia carriers: a multinational study. Haemophilia. ISSN 1351-8216. 22(6), p. 912–918. doi: 10.1111/hae.13089.
  • Holstein, K; Batorova, A; Carvalho, M.; Fijnvandraat, K.; Holme, Pål Andre & Kavakli, K [Show all 10 contributors for this article] (2016). Current view and outcome of ITI therapy - A change over time? Thrombosis Research. ISSN 0049-3848. 148, p. 38–44. doi: 10.1016/j.thromres.2016.10.015.
  • HAIG, YLVA; Enden, Tone Rønnaug; Grøtta, Ole Jørgen; Kløw, Nils-Einar; Slagsvold, Carl Erik & Ghanima, Waleed Khalid [Show all 13 contributors for this article] (2016). Post-thrombotic syndrome after catheter-directed thrombolysis for deep vein thrombosis (CaVenT): 5-year follow-up results of an open-label, randomised controlled trial. The Lancet Haematology. ISSN 2352-3026. 3(2), p. e64–e71. doi: 10.1016/S2352-3026%2815%2900248-3.
  • Valentino, Leonard A. & Holme, Pål Andre (2015). Should anti-inhibitor coagulant complex and tranexamic acid be used concomitantly? Haemophilia. ISSN 1351-8216. 21(6), p. 709–714. doi: 10.1111/hae.12723.
  • Fogarty, Patrick F.; Mancuso, Maria Elisa; Kasthuri, Ram S.; Bidlingmaier, Christoph M.; Chitlur, Meera B. & Gomez, Keith [Show all 12 contributors for this article] (2015). Presentation and management of acute coronary syndromes among adult persons with haemophilia: Results of an international, retrospective, 10-year survey. Haemophilia. ISSN 1351-8216. 21(5), p. 589–597. doi: 10.1111/hae.12652.
  • Ghanima, Waleed Khalid; Khelif, Abderrahim; Waage, Anders; Michel, Marc; Tjønnfjord, Geir Erland & Romdhan, Neila Ben [Show all 9 contributors for this article] (2015). Rituximab as second-line treatment for adult immune thrombocytopenia (the RITP trial): A multicentre, randomised, double-blind, placebo-controlled trial. The Lancet. ISSN 0140-6736. 385(9978), p. 1653–1661. doi: 10.1016/S0140-6736%2814%2961495-1.
  • Tran, Hoa Thi Tuyet; Sørensen, B.; Bjørnsen, Stine; Pripp, Are Hugo; Tjønnfjord, Geir Erland & Holme, Pål Andre (2015). Monitoring bypassing agent therapy - a prospective crossover study comparing thromboelastometry and thrombin generation assay. Haemophilia. ISSN 1351-8216. 21(2), p. 275–283. doi: 10.1111/hae.12570.
  • Tvedt, Tor Henrik Anderson; Holme, Pål Andre & Bruserud, Øystein (2014). En mann i 80-årene med muskelstivhet og hudblødninger 1058. Tidsskrift for Den norske legeforening. ISSN 0029-2001. 134(10), p. 1058–1061. doi: 10.4045/tidsskr.13.0817.
  • Kristiansen, Annette; Brandt, Linn; Agoritsas, Thomas; Akl, Elie A.; Berge, Eivind & Bondi, Johan Fridtjof [Show all 19 contributors for this article] (2014). Adaptation of trustworthy guidelines developed using the GRADE methodology: a novel five-step process. Chest. ISSN 0012-3692. 146(3), p. 727–734. doi: 10.1378/chest.13-2828.
  • Husøy, Magnus Andreas Rognlien; Brinch, Lorentz; Tjønnfjord, Geir Erland; Gedde-Dahl, Tobias Jr.; Heldal, Dag & Holme, Pål Andre [Show all 16 contributors for this article] (2014). Allogen stamcelletransplantasjon hos voksne 1985-2012. Tidsskrift for Den norske legeforening. ISSN 0029-2001. 134(16), p. 1569–1575. doi: 10.4045/tidsskr.13.1415.
  • WESTBERG, MARIANNE; Paus, Albert Collett; Holme, Pål Andre & Tjønnfjord, Geir Erland (2014). Haemophilic arthropathy: Long-term outcomes in 107 primary total knee arthroplasties. Knee (Oxford). ISSN 0968-0160. 21(1), p. 147–150. doi: 10.1016/j.knee.2013.09.010.
  • Tran, Hoa Thi Tuyet; Sørensen, B.; Rea, C.J.; Bjørnsen, Stine; Ueland, Thor & Pripp, Are Hugo [Show all 8 contributors for this article] (2014). Tranexamic acid as adjunct therapy to bypassing agents in haemophilia A patients with inhibitors. Haemophilia. ISSN 1351-8216. 20(3), p. 369–375. doi: 10.1111/hae.12318.
  • Misceo, Doriana; Holmgren, Asbjørn; Louch, William Edward; Holme, Pål Andre; Mizobuchi, Masahiro & Morales, Raul J. [Show all 14 contributors for this article] (2014). A Dominant STIM1 Mutation Causes Stormorken Syndrome. Human Mutation. ISSN 1059-7794. 35(5), p. 556–564. doi: 10.1002/humu.22544.
  • Tran, Hoa Thi Tuyet; Tjønnfjord, Geir Erland & Holme, Pål Andre (2014). Use of thromboelastography and thrombin generation assay to predict clinical phenotype in patients with severe FVII deficiency. Haemophilia. ISSN 1351-8216. 20(1), p. 141–146. doi: 10.1111/hae.12256.
  • Mathijssen, Natascha C.J.; Masereeuw, Roselinde; Holme, Pål Andre; van Kraaij, Marian G.J.; Laros-van Gorkom, Britta A.P. & Peyvandi, Flora [Show all 7 contributors for this article] (2013). Increased volume of distribution for recombinant activated factor VII and longer plasma-derived factor VII half-life may explain their long lasting prophylactic effect. Thrombosis Research. ISSN 0049-3848. 132(2), p. 256–262. doi: 10.1016/j.thromres.2013.05.027.
  • van Geffen, Mark; Mathijssen, Natascha C.J.; Holme, Pål Andre; Laros-van Gorkom, Britta A.P.; van Kraaij, Marian G.J. & Masereeuw, Roselinde [Show all 8 contributors for this article] (2013). Pharmacodynamics of recombinant activated factor VII and plasma-derived factor VII in a cohort of severe FVII deficient patients. Thrombosis Research. ISSN 0049-3848. 132(1), p. 116–122. doi: 10.1016/j.thromres.2013.04.021.
  • Vetlesen, Annette; Holme, Pål Andre; Lyberg, Torstein & Kjeldsen-Kragh, Jens (2012). Recovery, survival, and function of transfused platelets and detection of platelet engraftment after allogeneic stem cell transplantation. Transfusion. ISSN 0041-1132. 52(6), p. 1321–1332. doi: 10.1111/j.1537-2995.2011.03442.x.
  • Holmström, M.; Tran, Hoa Thi Tuyet & Holme, Pål Andre (2012). Combined treatment with APCC (FEIBA (R)) and tranexamic acid in patients with haemophilia A with inhibitors and in patients with acquired haemophilia A - a two-centre experience. Haemophilia. ISSN 1351-8216. 18(4), p. 544–549. doi: 10.1111/j.1365-2516.2012.02748.x.
  • Enden, Tone Rønnaug; HAIG, YLVA; Klow, Nils-Einar; Slagsvold, Carl Erik; Sandvik, Leiv & Ghanima, Waleed Khalid [Show all 12 contributors for this article] (2012). Long-term outcome after additional catheter-directed thrombolysis versus standard treatment for acute iliofemoral deep vein thrombosis (the CaVenT study): a randomised controlled trial. The Lancet. ISSN 0140-6736. 379(9810), p. 31–38. doi: 10.1016/S0140-6736%2811%2961753-4.
  • Batorova, A; Holme, Pål Andre; Gringeri, A; Richards, M.; Hermans, C. & Altisent, C. [Show all 8 contributors for this article] (2012). Continuous infusion in haemophilia: current practice in Europe. Haemophilia. ISSN 1351-8216. 18(5), p. 753–759. doi: 10.1111/j.1365-2516.2012.02810.x.
  • Lassila, Riita; Holme, Pål Andre; Landorph, Andrea; Petrini, Pia; Onundarson, Páll T. & Hillarp, Andreas (2011). Nordic Haemophilia Council's Practical Guidelines on Diagnosis and Management of von Willebrand Disease. Seminars in Thrombosis and Hemostasis. ISSN 0094-6176. 37(5), p. 495–502. doi: 10.1055/s-0031-1281034.
  • Tran, Hoa Thi Tuyet; Tjønnfjord, Geir Erland; Paus, Albert Collett & Holme, Pål Andre (2011). rFVIIa administered by continuous infusion during surgery in patients with severe congenital FVII deficiency. Haemophilia. ISSN 1351-8216. 17(5), p. 764–770. doi: 10.1111/j.1365-2516.2011.02596.x.
  • Lassila, R; Antovic, Jovan P; Armstrong, Elina; Baghaei, Fariba; Dalsgaard-Nielsen, Jørn & Hilllarp, Andreas [Show all 11 contributors for this article] (2011). Practical viewpoints on the diagnosis and management of heparin induced thrombocytopenia. Seminars in Thrombosis and Hemostasis. ISSN 0094-6176. 37(3), p. 328–335. doi: 10.1055/s-0031-1274516.
  • Ghanima, Waleed Khalid; Holme, Pål Andre & Tjønnfjord, Geir Erland (2010). Immunologisk trombocytopeni - patofysiologi og behandling :. Tidsskrift for Den norske legeforening. ISSN 0029-2001. 130(21), p. 2120–2123.
  • Perry, Dewayne; Berntorp, E; Tait, C; Dolan, G; Holme, Pål Andre & Laffan, M [Show all 12 contributors for this article] (2010). FEIBA prophylaxis in haemophilia patients: a clinical update and treatment recommendations. Haemophilia. ISSN 1351-8216. 16(1), p. 80–89. doi: 10.1111/j.1365-2516.2009.02104.x.
  • Astermark, J; Negrier, C; Hermans, C.; Holme, Pål Andre; Klamroth, R & Kotsi, P [Show all 12 contributors for this article] (2009). European curriculum for thrombosis and haemostasis. Haemophilia. ISSN 1351-8216. 15(1), p. 337–344. doi: 10.1111/j.1365-2516.2008.01836.x.
  • Enden, Tone Rønnaug; Kløw, Nils-Einar; Sandvik, Leiv; Slagsvold, Carl Erik; Ghanima, Waleed & Hafsahl, Geir [Show all 11 contributors for this article] (2009). Catheter-directed thrombolysis versus anticoagulant therapy alone in deep vein thrombosis: Results of an open randomized, controlled trial reporting on short term patency. Journal of Thrombosis and Haemostasis. ISSN 1538-7933. 7(8), p. 1268–1275. doi: 10.1111/j.1538-7836.2009.03464.x.
  • Negaard, Helene Francisca Stigter; Iversen, Per Ole; Østenstad, Bjørn; Iversen, Nina; Holme, Pål Andre & Sandset, Per Morten (2008). Hypercoagulability in patients with haematological neoplasia: No apparent initiation by tissue factor. Thrombosis and Haemostasis. ISSN 0340-6245. 99, p. 1040–1048. doi: 10.1160/TH07-09-0541.
  • Enden, Tone; Sandvik, Leiv; Kløw, Nils-Einar; Hafsahl, Geir; Holme, Pål Andre & Holmen, Lars Olaf [Show all 11 contributors for this article] (2007). Catheter-directed venous thrombolysis in acute iliofemoral vein thrombosis (CaVenT) study: Rationale and design of a multicenter, randomized, controlled, clinical trial (NCT00251771). American Heart Journal. ISSN 0002-8703. 154, p. 808–814. doi: 10.1016/j.ahj.2007.07.010.
  • Holme, Pål Andre; Brosstad, Frank Roger & Tjønnfjord, Geir Erland (2005). Acquired haemophilia: management of bleeds and immune therapy to eradicate autoantibodies. Haemophilia. ISSN 1351-8216. 11(5), p. 510–515. doi: 10.1111/j.1365-2516.2005.01136.

View all works in Cristin

  • Schultz, Nina Haagenrud; Holme, Pål Andre; Henriksson, Carola; Mowinckel, Marie-Christine; Sandset, Per Morten & Bratseth, Vibeke [Show all 7 contributors for this article] (2019). The influence of rivaroxaban on markers of fibrinolysis and endothelial cell activation/injury in patients with venous thrombosis. Thrombosis Research. ISSN 0049-3848. 177, p. 154–156. doi: 10.1016/j.thromres.2019.03.010.
  • Tran, Hoa Thi Tuyet; Holmström, M. & Holme, Pål Andre (2011). The combined treatment of APCC and tranexamic acid in patients with haemophilia a with inhibitors and in patients with acquired haemophilia a - a two-centre experience. Journal of Thrombosis and Haemostasis. ISSN 1538-7933. 9, p. 219–219.
  • Holme, Pål Andre; Berntorp, E; De Moerloose, P & Tait, R.C. (2011). Haematuria and hypertension in haemophilia - the H3 study. Haemophilia. ISSN 1351-8216. 17(2), p. 377–377.
  • Heldal, Dag; Brinch, Lorentz; Fløisand, Yngvar; Dybedal, Ingunn; Gedde-Dahl, Thobias & Holme, Pål Andre [Show all 8 contributors for this article] (2010). Long-term (>= 5 years) follow-up of a randomized study of allogeneic stem cell transplantation with stem cells from blood or bone marrow. Bone Marrow Transplantation. ISSN 0268-3369. 45, p. S155–S156.
  • Batorova, Angelika; Holme, Pål Andre; Gringeri, Alessandro; Fijnvandraat, K.; Richards, M. & Hermans, C. [Show all 8 contributors for this article] (2010). Inhibitor incidence in hemophilia A patients intensively treated with continuous infusion of factor VIII. Haemophilia. ISSN 1351-8216. 16, p. 67–67.
  • Brinch, Lorentz; Fløisand, Yngvar; Tjønnfjord, Geir Erland; Gedde-Dahl, Thobias; Heldal, Dag & Holme, Pål Andre [Show all 7 contributors for this article] (2009). Allogeneic blood stem cell transplants for AML using the Bu4Cy2 regimen in AML: long term experience. Bone Marrow Transplantation. ISSN 0268-3369. 43, p. S98–S98.
  • Holme, Pål Andre & Michelsen, Annika (2008). En 40 år gammel kvinne med svimmelhet og oppkast. Tidsskrift for Den norske legeforening. ISSN 0029-2001. 128(1413).

View all works in Cristin

Published June 12, 2013 10:27 AM - Last modified June 12, 2013 10:27 AM